{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T12:32:02Z","timestamp":1793277122601,"version":"4.5.0"},"reference-count":93,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T00:00:00Z","timestamp":1776643200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Respiratory Investigation"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.resinv.2026.101430","type":"journal-article","created":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T21:45:43Z","timestamp":1776375943000},"page":"101430","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Nontuberculous mycobacterial pulmonary disease: Epidemiology, prognostic determinants, and implications for treatment decision"],"prefix":"10.1016","volume":"64","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1611-4435","authenticated-orcid":false,"given":"Kazuaki","family":"Takeda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0696-5386","authenticated-orcid":false,"given":"Takahiro","family":"Takazono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1429-5706","authenticated-orcid":false,"given":"Hiroshi","family":"Mukae","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.resinv.2026.101430_bib1","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1164\/rccm.201111-2016OC","article-title":"Prevalence of nontuberculous mycobacterial lung disease in U.S. medicare beneficiaries","volume":"185","author":"Adjemian","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.resinv.2026.101430_bib2","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.3201\/eid2206.151086","article-title":"Epidemiology of pulmonary nontuberculous mycobacterial disease, Japan","volume":"22","author":"Namkoong","year":"2016","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.resinv.2026.101430_bib3","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.ijid.2022.10.013","article-title":"Global trends of pulmonary infections with nontuberculous mycobacteria: a systematic review","volume":"125","author":"Dahl","year":"2022","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.resinv.2026.101430_bib4","doi-asserted-by":"crossref","first-page":"e321","DOI":"10.1093\/cid\/ciaa810","article-title":"Trends in the nontuberculous mycobacterial disease mortality rate in Japan: a nationwide observational study, 1997\u20132016","volume":"73","author":"Harada","year":"2021","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.resinv.2026.101430_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijid.2025.107932","article-title":"Trends in nontuberculous mycobacterial disease mortality based on 2000\u20132022 data from 83 countries","volume":"158","author":"Harada","year":"2025","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.resinv.2026.101430_bib6","doi-asserted-by":"crossref","DOI":"10.1183\/23120541.00337-2024","article-title":"Laboratory-based surveillance of nontuberculous mycobacterial pulmonary disease in Japan","volume":"11","author":"Hamaguchi","year":"2025","journal-title":"ERJ Open Res"},{"key":"10.1016\/j.resinv.2026.101430_bib7","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.resinv.2017.11.001","article-title":"Clinical significance and epidemiologic analyses of Mycobacterium avium and Mycobacterium intracellulare lung disease from post-marketing surveillance","volume":"56","author":"Suzuki","year":"2018","journal-title":"Respir Investig"},{"key":"10.1016\/j.resinv.2026.101430_bib8","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.jiac.2024.02.018","article-title":"The epidemiology of pulmonary Mycobacterium abscessus species in Japanese population","volume":"30","author":"Ihara","year":"2024","journal-title":"J Infect Chemother"},{"key":"10.1016\/j.resinv.2026.101430_bib9","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1016\/j.resinv.2024.09.007","article-title":"Epidemiological trends and clinical relevance of nontuberculous mycobacterial pulmonary disease in a referral hospital in Japan, 2017\u20132021","volume":"62","author":"Ito","year":"2024","journal-title":"Respir Investig"},{"key":"10.1016\/j.resinv.2026.101430_bib10","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.ccm.2023.08.012","article-title":"Global epidemiology of nontuberculous mycobacterial pulmonary disease: a review","volume":"44","author":"Prevots","year":"2023","journal-title":"Clin Chest Med"},{"key":"10.1016\/j.resinv.2026.101430_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.rmed.2020.106164","article-title":"Epidemiology of nontuberculous mycobacterial pulmonary disease in Europe and Japan by Delphi estimation","volume":"173","author":"Schildkraut","year":"2020","journal-title":"Respir Med"},{"key":"10.1016\/j.resinv.2026.101430_bib12","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1080\/17476348.2023.2283135","article-title":"A narrative review of nontuberculous mycobacterial pulmonary disease: microbiology, epidemiology, diagnosis, and management challenges","volume":"17","author":"Hamed","year":"2023","journal-title":"Expet Rev Respir Med"},{"key":"10.1016\/j.resinv.2026.101430_bib13","doi-asserted-by":"crossref","first-page":"343","DOI":"10.3201\/eid170310060","article-title":"Nontuberculous mycobacteria in respiratory tract infections, eastern Asia","volume":"17","author":"Simons","year":"2011","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.resinv.2026.101430_bib14","doi-asserted-by":"crossref","first-page":"93","DOI":"10.2217\/fmb.13.138","article-title":"Diseases caused by nontuberculous mycobacteria in Asia","volume":"9","author":"Lai","year":"2014","journal-title":"Future Microbiol"},{"key":"10.1016\/j.resinv.2026.101430_bib15","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.3904\/kjim.2019.395","article-title":"Age- and sex-related characteristics of the increasing trend of nontuberculous mycobacteria pulmonary disease in a tertiary hospital in South Korea from 2006 to 2016","volume":"35","author":"Park","year":"2020","journal-title":"Korean J Intern Med (Engl Ed)"},{"key":"10.1016\/j.resinv.2026.101430_bib16","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1186\/s12879-024-09059-9","article-title":"Nontuberculous mycobacteria testing and culture positivity in the United States","volume":"24","author":"Marshall","year":"2024","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.resinv.2026.101430_bib17","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1183\/09031936.00149212","article-title":"The geographic diversity of nontuberculous mycobacteria isolated from pulmonary samples: an NTM-NET collaborative study","volume":"42","author":"Hoefsloot","year":"2013","journal-title":"Eur Respir J"},{"key":"10.1016\/j.resinv.2026.101430_bib18","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.jinf.2023.03.010","article-title":"Species distribution among patients with nontuberculous mycobacteria pulmonary disease in Europe","volume":"87","author":"Dahl","year":"2023","journal-title":"J Infect"},{"key":"10.1016\/j.resinv.2026.101430_bib19","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.931876","article-title":"Modulating macrophage function to reinforce host innate resistance against Mycobacterium avium complex infection","volume":"13","author":"Park","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.resinv.2026.101430_bib20","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s12979-022-00277-w","article-title":"NF-\u03baB, a culprit of both inflamm-ageing and declining immunity?","volume":"19","author":"Songkiatisak","year":"2022","journal-title":"Immun Ageing"},{"key":"10.1016\/j.resinv.2026.101430_bib21","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.chest.2024.03.023","article-title":"Nationwide increasing incidence of nontuberculous mycobacterial diseases among adults in Denmark: eighteen years of Follow-Up","volume":"166","author":"Pedersen","year":"2024","journal-title":"Chest"},{"key":"10.1016\/j.resinv.2026.101430_bib22","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1186\/s12879-024-09965-y","article-title":"Nontuberculous mycobacterial pulmonary disease (NTM PD) incidence trends in the United States, 2010-2019","volume":"24","author":"Bents","year":"2024","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.resinv.2026.101430_bib23","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-025-14348-7","article-title":"Multicentre retrospective observational study for development and validation of MAC prognostic score model","volume":"15","author":"Takeda","year":"2025","journal-title":"Sci Rep"},{"key":"10.1016\/j.resinv.2026.101430_bib24","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1164\/rccm.202004-1418OC","article-title":"BACES score for predicting mortality in nontuberculous mycobacterial pulmonary disease","volume":"203","author":"Kim","year":"2021","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.resinv.2026.101430_bib25","doi-asserted-by":"crossref","first-page":"7348","DOI":"10.1038\/s41598-023-34576-z","article-title":"The factors associated with mortality and progressive disease of nontuberculous mycobacterial lung disease: a systematic review and meta-analysis","volume":"13","author":"Hwang","year":"2023","journal-title":"Sci Rep"},{"key":"10.1016\/j.resinv.2026.101430_bib26","doi-asserted-by":"crossref","DOI":"10.1177\/17534666251323181","article-title":"Pulmonary nontuberculous mycobacterial infections among women with cystic fibrosis and non-cystic fibrosis bronchiectasis","volume":"19","author":"Gross","year":"2025","journal-title":"Ther Adv Respir Dis"},{"key":"10.1016\/j.resinv.2026.101430_bib27","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/j.chest.2023.06.014","article-title":"Risk factors for nontuberculous mycobacterial pulmonary disease: a systematic literature review and meta-analysis","volume":"164","author":"Loebinger","year":"2023","journal-title":"Chest"},{"key":"10.1016\/j.resinv.2026.101430_bib28","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s42358-024-00357-z","article-title":"Clinical course of nontuberculous mycobacterial pulmonary disease in patients with rheumatoid arthritis","volume":"64","author":"Kwak","year":"2024","journal-title":"Adv Rheumatol"},{"key":"10.1016\/j.resinv.2026.101430_bib29","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00798-2019","article-title":"Prognostic factors associated with long-term mortality in 1445 patients with nontuberculous mycobacterial pulmonary disease: a 15-year follow-up study","volume":"55","author":"Jhun","year":"2020","journal-title":"Eur Respir J"},{"key":"10.1016\/j.resinv.2026.101430_bib30","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1186\/s12879-017-2544-0","article-title":"Development and validation of a prognostic scoring model for Mycobacterium avium complex lung disease: an observational cohort study","volume":"17","author":"Kumagai","year":"2017","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.resinv.2026.101430_bib31","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1038\/nri.2016.90","article-title":"Sex differences in immune responses","volume":"16","author":"Klein","year":"2016","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.resinv.2026.101430_bib32","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1046\/j.1365-2249.2001.01474.x","article-title":"Effect of oestrogen on Mycobacterium avium complex pulmonary infection in mice","volume":"123","author":"Tsuyuguchi","year":"2001","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.resinv.2026.101430_bib33","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.3201\/eid2108.141846","article-title":"Risk for mycobacterial disease among patients with rheumatoid arthritis, Taiwan, 2001\u20132011","volume":"21","author":"Liao","year":"2015","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.resinv.2026.101430_bib34","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-21511-x","article-title":"Severity of underweight affects the development of nontuberculous mycobacterial pulmonary disease; a nationwide longitudinal study","volume":"12","author":"Kang","year":"2022","journal-title":"Sci Rep"},{"key":"10.1016\/j.resinv.2026.101430_bib35","article-title":"The role of the adipokine leptin in immune cell function in health and disease","volume":"11","author":"Kiernan","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.resinv.2026.101430_bib36","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1159\/000231975","article-title":"Elevated serum adiponectin level in patients with mycobacterium avium-intracellulare complex pulmonary disease","volume":"79","author":"Tasaka","year":"2010","journal-title":"Respiration"},{"key":"10.1016\/j.resinv.2026.101430_bib37","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/nri2921","article-title":"Adipokines in inflammation and metabolic disease","volume":"11","author":"Ouchi","year":"2011","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.resinv.2026.101430_bib38","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1086\/519383","article-title":"The recovery of mycobacterium avium-intracellulare complex (MAC) from the residential bathrooms of patients with pulmonary MAC","volume":"45","author":"Nishiuchi","year":"2007","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.resinv.2026.101430_bib39","doi-asserted-by":"crossref","first-page":"419","DOI":"10.3201\/eid1703.101510","article-title":"Nontuberculous mycobacteria from household plumbing of patients with nontuberculous mycobacteria disease","volume":"17","author":"Falkinham","year":"2011","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.resinv.2026.101430_bib40","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1093\/aje\/kwj159","article-title":"Environmental risk factors for infection with Mycobacterium avium complex","volume":"164","author":"Reed","year":"2006","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.resinv.2026.101430_bib41","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1513\/AnnalsATS.202101-053OC","article-title":"Nontuberculous mycobacteria infection risk and trace metals in surface water: a population-based ecologic epidemiologic study in Oregon","volume":"19","author":"Lipner","year":"2022","journal-title":"Ann Am Thorac Soc"},{"key":"10.1016\/j.resinv.2026.101430_bib42","doi-asserted-by":"crossref","DOI":"10.1097\/EE9.0000000000000220","article-title":"Vanadium in groundwater aquifers increases the risk of MAC pulmonary infection in O'ahu, hawai'i","volume":"6","author":"Lipner","year":"2022","journal-title":"Environ Epidemiol"},{"key":"10.1016\/j.resinv.2026.101430_bib43","doi-asserted-by":"crossref","DOI":"10.1128\/aem.00018-22","article-title":"Soil properties and moisture synergistically influence nontuberculous mycobacterial prevalence in natural environments of hawai'i","volume":"88","author":"Parsons","year":"2022","journal-title":"Appl Environ Microbiol"},{"key":"10.1016\/j.resinv.2026.101430_bib44","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1378\/chest.13-2058","article-title":"Risk of mycobacterial infections associated with rheumatoid arthritis in Ontario, Canada","volume":"146","author":"Brode","year":"2014","journal-title":"Chest"},{"key":"10.1016\/j.resinv.2026.101430_bib45","doi-asserted-by":"crossref","DOI":"10.1136\/bmjresp-2025-003397","article-title":"Rheumatoid arthritis and risk of non-tuberculous mycobacterial pulmonary disease: a nationwide longitudinal cohort study","volume":"12","author":"Yang","year":"2025","journal-title":"BMJ Open Respir Res"},{"key":"10.1016\/j.resinv.2026.101430_bib46","article-title":"Risk factors and outcomes of nontuberculous mycobacterial disease among rheumatoid arthritis patients: a case-control study in a TB endemic area","volume":"6","author":"Liao","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.resinv.2026.101430_bib47","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1136\/thoraxjnl-2014-206470","article-title":"Increased risk of mycobacterial infections associated with anti-rheumatic medications","volume":"70","author":"Brode","year":"2015","journal-title":"Thorax"},{"key":"10.1016\/j.resinv.2026.101430_bib48","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1093\/mr\/roab032","article-title":"Rheumatoid arthritis with nontuberculous mycobacterial pulmonary disease: a retrospective, single-centre cohort study","volume":"32","author":"Takei","year":"2022","journal-title":"Mod Rheumatol"},{"key":"10.1016\/j.resinv.2026.101430_bib49","doi-asserted-by":"crossref","first-page":"6998","DOI":"10.3390\/jcm12226998","article-title":"Association of tumor necrosis factor inhibitors with the risk of nontuberculous mycobacterial infection in patients with rheumatoid arthritis: a nationwide cohort study","volume":"12","author":"Park","year":"2023","journal-title":"J Clin Med"},{"key":"10.1016\/j.resinv.2026.101430_bib50","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0243110","article-title":"Mortality in rheumatoid arthritis patients with pulmonary nontuberculous mycobacterial disease: a retrospective cohort study","volume":"15","author":"Mori","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.resinv.2026.101430_bib51","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.resinv.2024.02.005","article-title":"Risk factor of non-tuberculous mycobacterium infection in patients with rheumatoid arthritis and other autoimmune diseases receiving biologic agents: a multicenter retrospective study","volume":"62","author":"Ashizawa","year":"2024","journal-title":"Respir Investig"},{"key":"10.1016\/j.resinv.2026.101430_bib52","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1016\/j.chest.2020.12.020","article-title":"Impact of bronchiectasis on incident nontuberculous mycobacterial pulmonary disease: a 10-year national cohort study","volume":"159","author":"Yang","year":"2021","journal-title":"Chest"},{"key":"10.1016\/j.resinv.2026.101430_bib53","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1164\/rccm.202307-1165OC","article-title":"Five-year outcomes among U.S. bronchiectasis and NTM research registry patients","volume":"210","author":"Aksamit","year":"2024","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.resinv.2026.101430_bib54","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1186\/s12890-024-03337-7","article-title":"Epidemiology of bronchiectasis at a single center in Japan: a retrospective cohort study","volume":"24","author":"Hashimoto","year":"2024","journal-title":"BMC Pulm Med"},{"key":"10.1016\/j.resinv.2026.101430_bib55","doi-asserted-by":"crossref","DOI":"10.1136\/bmjresp-2024-002373","article-title":"Chronic obstructive pulmonary disease is a risk factor for non-tuberculous mycobacterial pulmonary disease: a population-based matched cohort study","volume":"12","author":"Jang","year":"2025","journal-title":"BMJ Open Respir Res"},{"key":"10.1016\/j.resinv.2026.101430_bib56","doi-asserted-by":"crossref","DOI":"10.1183\/23120541.00911-2023","article-title":"Nontuberculous mycobacterial pulmonary disease added burden to COPD and bronchiectasis in Japan","volume":"10","author":"Wang","year":"2024","journal-title":"ERJ Open Res"},{"key":"10.1016\/j.resinv.2026.101430_bib57","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1136\/thoraxjnl-2012-201772","article-title":"Chronic respiratory disease, inhaled corticosteroids and risk of non-tuberculous mycobacteriosis","volume":"68","author":"Andrejak","year":"2013","journal-title":"Thorax"},{"key":"10.1016\/j.resinv.2026.101430_bib58","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1159\/000525980","article-title":"Inhaled corticosteroids and mycobacterial infection in patients with chronic airway diseases: a systematic review and meta-analysis","volume":"101","author":"You","year":"2022","journal-title":"Respiration"},{"key":"10.1016\/j.resinv.2026.101430_bib59","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1093\/infdis\/jiab428","article-title":"Inhaled corticosteroids increase risk of nontuberculous mycobacterial lung disease: a nested case-control study and meta-analysis","volume":"225","author":"Shu","year":"2022","journal-title":"J Infect Dis"},{"key":"10.1016\/j.resinv.2026.101430_bib60","doi-asserted-by":"crossref","DOI":"10.1111\/myc.70083","article-title":"Risk factors and long-term prognosis for coinfection of nontuberculous mycobacterial pulmonary disease and chronic pulmonary aspergillosis: a multicentre observational study in Japan","volume":"68","author":"Tanaka","year":"2025","journal-title":"Mycoses"},{"key":"10.1016\/j.resinv.2026.101430_bib61","doi-asserted-by":"crossref","first-page":"346","DOI":"10.3390\/jof6040346","article-title":"Chronic pulmonary aspergillosis following nontuberculous mycobacterial infections: an emerging disease","volume":"6","author":"Phoompoung","year":"2020","journal-title":"J Fungi"},{"key":"10.1016\/j.resinv.2026.101430_bib62","doi-asserted-by":"crossref","DOI":"10.1111\/myc.70022","article-title":"Risk factors and prognostic effects of aspergillosis as a complication of nontuberculous mycobacterial pulmonary disease: a nested case-control study","volume":"68","author":"Takazono","year":"2025","journal-title":"Mycoses"},{"key":"10.1016\/j.resinv.2026.101430_bib63","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1513\/AnnalsATS.201902-181CME","article-title":"Pleuroparenchymal fibroelastosis. A review of clinical, radiological, and pathological characteristics","volume":"16","author":"Chua","year":"2019","journal-title":"Ann Am Thorac Soc"},{"key":"10.1016\/j.resinv.2026.101430_bib64","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijid.2024.107233","article-title":"Distinctive clinical features of radiological pleuroparenchymal fibroelastosis with nontuberculous mycobacterial pulmonary disease: a multicenter retrospective cohort study","volume":"148","author":"Tanaka","year":"2024","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.resinv.2026.101430_bib65","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1093\/mmy\/myv093","article-title":"The risk factors for developing of chronic pulmonary aspergillosis in nontuberculous mycobacteria patients and clinical characteristics and outcomes in chronic pulmonary aspergillosis patients coinfected with nontuberculous mycobacteria","volume":"54","author":"Takeda","year":"2016","journal-title":"Med Mycol"},{"key":"10.1016\/j.resinv.2026.101430_bib66","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0185774","article-title":"Natural course of the nodular bronchiectatic form of Mycobacterium avium complex lung disease: long-Term radiologic change without treatment","volume":"12","author":"Park","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.resinv.2026.101430_bib67","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.02503-2016","article-title":"Outcomes of Mycobacterium avium complex lung disease based on clinical phenotype","volume":"50","author":"Koh","year":"2017","journal-title":"Eur Respir J"},{"key":"10.1016\/j.resinv.2026.101430_bib68","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1164\/rccm.201107-1203OC","article-title":"Prognostic factors of 634 HIV-Negative patients with Mycobacterium avium complex lung disease","volume":"185","author":"Hayashi","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.resinv.2026.101430_bib69","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1378\/chest.12-0494","article-title":"Clinical significance of the differentiation between Mycobacterium avium and Mycobacterium intracellulare in M avium complex lung disease","volume":"142","author":"Koh","year":"2012","journal-title":"Chest"},{"key":"10.1016\/j.resinv.2026.101430_bib70","doi-asserted-by":"crossref","first-page":"4439","DOI":"10.1128\/JCM.02127-14","article-title":"Significant difference in drug susceptibility distribution between Mycobacterium avium and Mycobacterium intracellulare","volume":"52","author":"Renvois\u00e9","year":"2014","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.resinv.2026.101430_bib71","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.jiac.2017.10.022","article-title":"Differences in drug susceptibility pattern between Mycobacterium avium and Mycobacterium intracellulare isolated in respiratory specimens","volume":"24","author":"Cho","year":"2018","journal-title":"J Infect Chemother"},{"key":"10.1016\/j.resinv.2026.101430_bib72","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1164\/rccm.201003-0395OC","article-title":"Clinical significance of differentiation of Mycobacterium massiliense from Mycobacterium abscessus","volume":"183","author":"Koh","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.resinv.2026.101430_bib73","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.ijantimicag.2013.04.029","article-title":"Further isolation of Mycobacterium abscessus subsp. abscessus and subsp. bolletii in different regions of Japan and susceptibility of these isolates to antimicrobial agents","volume":"42","author":"Yoshida","year":"2013","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.resinv.2026.101430_bib74","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-91757-4","article-title":"Nationwide surveillance of antimicrobial susceptibility of 509 rapidly growing mycobacteria strains isolated from clinical specimens in Japan","volume":"11","author":"Kamada","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.resinv.2026.101430_bib75","doi-asserted-by":"crossref","DOI":"10.1128\/spectrum.00218-24","article-title":"Minimum inhibitory concentrations of azithromycin in clinical isolates of Mycobacterium avium complex in Japan","volume":"12","author":"Uwamino","year":"2024","journal-title":"Microbiol Spectr"},{"key":"10.1016\/j.resinv.2026.101430_bib76","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/cid\/ciaa241","article-title":"Treatment of nontuberculous mycobacterial pulmonary disease: an official ATS\/ERS\/ESCMID\/IDSA clinical practice guideline","volume":"71","author":"Daley","year":"2020","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.resinv.2026.101430_bib77","doi-asserted-by":"crossref","first-page":"6758","DOI":"10.1128\/AAC.01240-16","article-title":"Clinical characteristics, treatment outcomes, and resistance mutations associated with macrolide-resistant Mycobacterium avium complex lung disease","volume":"60","author":"Moon","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.resinv.2026.101430_bib78","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1128\/AAC.01275-08","article-title":"A novel gene, erm(41), confers inducible macrolide resistance to clinical isolates of Mycobacterium abscessus but is absent from Mycobacterium chelonae","volume":"53","author":"Nash","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.resinv.2026.101430_bib79","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1186\/s12931-019-1258-9","article-title":"Clinical characteristics and treatment outcomes of patients with macrolide-resistant Mycobacterium avium complex pulmonary disease: a systematic review and meta-analysis","volume":"20","author":"Park","year":"2019","journal-title":"Respir Res"},{"key":"10.1016\/j.resinv.2026.101430_bib80","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1093\/infdis\/174.6.1218","article-title":"Effect of ethambutol on emergence of clarithromycin-resistant Mycobacterium avium complex in the beige mouse model","volume":"174","author":"Bermudez","year":"1996","journal-title":"J Infect Dis"},{"key":"10.1016\/j.resinv.2026.101430_bib81","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1086\/514116","article-title":"A randomized evaluation of ethambutol for prevention of relapse and drug resistance during treatment of Mycobacterium avium complex bacteremia with clarithromycin-based combination therapy. California collaborative treatment group","volume":"176","author":"Dub\u00e9","year":"1997","journal-title":"J Infect Dis"},{"key":"10.1016\/j.resinv.2026.101430_bib82","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.1513\/AnnalsATS.201604-246OC","article-title":"Macrolide-resistant Mycobacterium avium complex lung disease: analysis of 102 consecutive cases","volume":"13","author":"Morimoto","year":"2016","journal-title":"Ann Am Thorac Soc"},{"key":"10.1016\/j.resinv.2026.101430_bib83","doi-asserted-by":"crossref","DOI":"10.1128\/aac.01213-24","article-title":"Variability of macrolide-resistant profile in Mycobacterium avium complex pulmonary disease","volume":"68","author":"Fukushima","year":"2024","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.resinv.2026.101430_bib84","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1378\/chest.13-2538","article-title":"Macrolide\/Azalide therapy for nodular\/bronchiectatic Mycobacterium avium complex lung disease","volume":"146","author":"Wallace","year":"2014","journal-title":"Chest"},{"key":"10.1016\/j.resinv.2026.101430_bib85","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1016\/j.resinv.2024.09.012","article-title":"Reassessment of the relevance between microbiological macrolide-induced resistance and diagnosis and treatment outcome of mycobacterium abscessus-related pulmonary disease","volume":"62","author":"Yoshida","year":"2024","journal-title":"Respir Investig"},{"key":"10.1016\/j.resinv.2026.101430_bib86","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.chest.2023.10.006","article-title":"External validation of the BACES score in Canadian patients with nontuberculous mycobacterial pulmonary disease","volume":"165","author":"Yan","year":"2024","journal-title":"Chest"},{"key":"10.1016\/j.resinv.2026.101430_bib87","doi-asserted-by":"crossref","first-page":"7495","DOI":"10.1038\/s41598-023-33782-z","article-title":"Usefulness of the BACES score in nontuberculous mycobacterial pulmonary disease for various clinical outcomes","volume":"13","author":"Kim","year":"2023","journal-title":"Sci Rep"},{"key":"10.1016\/j.resinv.2026.101430_bib88","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofaf565","article-title":"Developing a simple scoring system on CT findings for predicting treatment failure in Mycobacterium avium complex pulmonary disease: the BCD (bronchiectasis and cavity distribution) score","volume":"12","author":"Hayashi","year":"2025","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.resinv.2026.101430_bib89","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.chest.2020.08.2055","article-title":"Development of drugs for nontuberculous mycobacterial disease: clinicians' interpretation of a US food and drug administration workshop","volume":"159","author":"Flume","year":"2021","journal-title":"Chest"},{"key":"10.1016\/j.resinv.2026.101430_bib90","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00537-2016","article-title":"Natural history of Mycobacterium avium complex lung disease in untreated patients with stable course","volume":"49","author":"Hwang","year":"2017","journal-title":"Eur Respir J"},{"key":"10.1016\/j.resinv.2026.101430_bib91","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.rmed.2019.03.014","article-title":"Long-term natural history of non-cavitary nodular bronchiectatic nontuberculous mycobacterial pulmonary disease","volume":"151","author":"Moon","year":"2019","journal-title":"Respir Med"},{"key":"10.1016\/j.resinv.2026.101430_bib92","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1016\/j.chest.2021.10.048","article-title":"Impact of time between diagnosis and treatment for nontuberculous mycobacterial pulmonary disease on culture conversion and all-cause mortality","volume":"161","author":"Im","year":"2022","journal-title":"Chest"},{"key":"10.1016\/j.resinv.2026.101430_bib93","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.chest.2024.03.024","article-title":"Rates and risk factors of progression in patients with nontuberculous mycobacterial pulmonary disease: secondary analysis of a prospective cohort study","volume":"166","author":"Hyung","year":"2024","journal-title":"Chest"}],"container-title":["Respiratory Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221253452600064X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221253452600064X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T12:57:51Z","timestamp":1778849871000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S221253452600064X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":93,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["S221253452600064X"],"URL":"https:\/\/doi.org\/10.1016\/j.resinv.2026.101430","relation":{},"ISSN":["2212-5345"],"issn-type":[{"value":"2212-5345","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nontuberculous mycobacterial pulmonary disease: Epidemiology, prognostic determinants, and implications for treatment decision","name":"articletitle","label":"Article Title"},{"value":"Respiratory Investigation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.resinv.2026.101430","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier B.V. on behalf of The Japanese Respiratory Society.","name":"copyright","label":"Copyright"}],"article-number":"101430"}}